12-Apr-17 Singaporean patients will soon be able to see their doctors from the comfort of their home, with the launch of a national video consultation platform. The cloud-based platform allows for video conferencing, file sharing and the display of medical reports or images during consultations. Six public institutions will launch the system, which is accessible via smartphone or computer. [image: Nadia Jansen Hassan / Channel News Asia]

11-Apr-17 China is seeing a growing interest from medical travellers seeking Traditional Chinese Medicine (TCM) as well as those seeking high-end western therapies and treatments in some of the world's best private healthcare centers. China's National Development and Reform Commission targets to build 10 TCM health tourism model zones offering medical treatment, wellness, recuperation and elder care by 2020. [image: Australian Business Forum]

11-Apr-17 The North American Free Trade Agreement has led to the transformation of Tijuana to become one of the world capitals in the manufacture of medical devices. The manufacturing units located in Tijuana make millions of medical devices from intravenous bags to artificial respirators. Many American med-device companies have manufacturing facilities in TiJuana, including Medtronic, Carefusion, and DJO Global. [image: John Francis Peters / New York Times]

 Insights

11-Apr-17 Boston-based Massachusetts General Hospital and Jiahui Health Network are pursuing a collaboration to create Jiahui International Hospital in China's Shanghai Province. The 300-bed hospital will focus on cancer care and research. Mass General Cancer Center will advise Jiahui as it launches a cancer center focused on breast, lung, gastrointestinal, lymphoma and myeloma treatment programs. [image: Partners Healthcare]

10-Apr-17 Korean biotech companies are drawing much interest and investment from well-known foreign investors including Bain Capital, Goldman Sachs and the state-run Chinese company Tsinghua Tongfang Group. Korea biotech firms, according to one investor "are second to none, in terms of technology but their values have been underestimated due to the small size of the domestic market.” [image: Business Korea]